US2007003598A1PendingUtilityA1
Osteogenic implants for soft tissue
Est. expiryAug 6, 2023(expired)· nominal 20-yr term from priority
Inventors:Hai H. Trieu
A61L 2300/45A61L 2300/602A61L 2300/254A61K 47/34A61L 2300/622A61F 2002/30677A61F 2002/444A61L 2430/38A61L 2300/414A61L 27/54A61K 47/32A61F 2002/30586A61K 9/0024
61
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
An osteogenic implant includes a degradation agent in solid form and an osteogenerative agent in solid form. The osteogenic implant is configured to release the degradation agent prior to releasing the osteogenerative agent.
Claims
exact text as granted — not AI-modified1 . An osteogenic implant comprising:
a degradation agent in solid form; and an osteogenerative agent in solid form; wherein the osteogenic implant is configured to release the degradation agent prior to releasing the osteogenerative agent.
2 . The osteogenic implant of claim 1 , wherein the osteogenerative agent is an osteoconductive agent.
3 . The osteogenic implant of claim 1 , wherein the osteogenerative agent is an osteoinductive agent.
4 . (canceled)
5 . The osteogenic implant of claim 1 , wherein the degradation agent includes a nucleolytic agent.
6 .- 7 . (canceled)
8 . The osteogenic implant of claim 1 , wherein the degradation agent is included in a microsphere.
9 . The osteogenic implant of claim 8 , wherein the microsphere is included in a solution.
10 . (canceled)
11 . The osteogenic implant of claim 1 , wherein the degradation agent is included in an outer layer of the osteogenic implant surrounding a core layer including the osteogenerative agent.
12 . The osteogenic implant of claim 1 , further including an outer layer having an opening, wherein the degradation agent is included in a first region within the outer layer and the osteogenerative agent is included in a second region within the outer layer.
13 . The osteogenic implant of claim 12 , wherein the first region is closer to the opening than the second region.
14 . The osteogenic implant of claim 1 , wherein the degradation agent is included in a polymeric matrix.
15 .- 16 . (canceled)
17 . The osteogenic implant of claim 1 , wherein the osteogenerative agent is included in a polymer matrix.
18 .- 19 . (canceled)
20 . The osteogenic implant of claim 1 , further comprising an anesthetic agent or an analgesic agent.
21 . The osteogenic implant of claim 20 , wherein the osteogenic implant is configured to release at least a portion of the anesthetic agent or the analgesic agent in conjunction with the degradation agent.
22 .- 24 . (canceled)
25 . The osteogenic implant of claim 1 , wherein the osteogenic implant includes an elongated form and a tapered end.
26 . An osteogenic implant comprising:
a first polymer matrix including a degradation agent; and a second polymer matrix including an osteogenerative agent; wherein the first polymer matrix is configured to release at least a portion of the degradation agent prior to time at which the second polymer matrix is configured to release the osteogenerative agent.
27 . The osteogenic implant of claim 26 , wherein the osteogenerative agent is an osteoconductive agent.
28 . The osteogenic implant of claim 26 , wherein the osteogenerative agent is an osteoinductive agent.
29 .- 32 . (canceled)
33 . The osteogenic implant of claim 26 , wherein the first polymeric matrix includes a hydrogel.
34 . The osteogenic implant of claim 26 , wherein the first polymeric matrix includes a bioresorbable polymer.
35 .- 36 . (canceled)
37 . The osteogenic implant of claim 26 , further comprising an anesthetic agent.
38 . The osteogenic implant of claim 37 , wherein the osteogenic implant is configured to release at least a portion of the anesthetic agent in conjunction with the degradation agent.
39 .- 40 . (canceled)
41 . A medical kit comprising:
an osteogenic implant including:
a degradation agent in solid form; and
an osteogenerative agent in solid form;
wherein the osteogenic implant is configured to release the degradation agent prior to releasing the osteogenerative agent; and
a tool configured to locate the osteogenic implant proximate to a vertebral structure.
42 . The medical kit of claim 41 , wherein the tool includes a lumen and wherein the osteogenic implant is configured to fit within the lumen.
43 .- 68 . (canceled)Join the waitlist — get patent alerts
Track US2007003598A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.